Larson Financial Group LLC raised its position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 33.0% in the third quarter, HoldingsChannel reports. The firm owned 4,088 shares of the medical research company’s stock after buying an additional 1,014 shares during the quarter. Larson Financial Group LLC’s holdings in Agilent Technologies were worth $607,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently made changes to their positions in A. Livelsberger Financial Advisory purchased a new stake in shares of Agilent Technologies in the 3rd quarter worth $28,000. Crewe Advisors LLC raised its stake in shares of Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after buying an additional 101 shares during the period. Ashton Thomas Securities LLC purchased a new position in shares of Agilent Technologies during the 3rd quarter valued at about $31,000. Ridgewood Investments LLC bought a new position in shares of Agilent Technologies during the 2nd quarter valued at approximately $29,000. Finally, Fortitude Family Office LLC increased its holdings in Agilent Technologies by 68.3% in the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after acquiring an additional 95 shares in the last quarter.
Insiders Place Their Bets
In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Agilent Technologies Stock Performance
Agilent Technologies Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be given a $0.248 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $0.99 annualized dividend and a yield of 0.74%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio (DPR) is currently 19.50%.
Analyst Ratings Changes
Several equities analysts have weighed in on A shares. Citigroup lifted their price target on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. UBS Group upped their target price on shares of Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Wells Fargo & Company initiated coverage on Agilent Technologies in a report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 price target on the stock. Barclays upped their price objective on Agilent Technologies from $135.00 to $145.00 and gave the stock an “underweight” rating in a research note on Tuesday, October 15th. Finally, Evercore ISI lifted their target price on Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $144.36.
Check Out Our Latest Report on A
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Further Reading
- Five stocks we like better than Agilent Technologies
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- What Are Trending Stocks? Trending Stocks Explained
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- 3 Warren Buffett Stocks to Buy Now
- Discover the 3 Best Performing Stocks That Went Public in 2024
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.